Navigation Links
Ancient mechanism for coping with stresses also gives cancer a boost
Date:9/20/2007

An ancient mechanism for coping with environmental stresses, including heat and toxic exposures, also helps cancerous tumors survive, reveals a new report in the Sept. 21, 2007, issue of Cell, a publication of Cell Press. The findings could lead to a new way to treat cancer and may also have implications for the treatment of neurodegenerative and other diseases, according to the researchers.

The scientists found that loss of the master controller of the "heat-shock response" dramatically limited the spontaneous formation of tumors in mice genetically predisposed to developing cancer, and those exposed to cancer-causing chemicals. Most importantly, they reported, depletion of the so-called heat-shock factor 1 (HSF1) in diverse previously established human cancer cell lines strongly impaired their growth and survival, while having little effect on normal cells.

"At a fundamental level, the ability of HSF1 to enable lethal malignancies is an unfortunate legacy of its ancient role in enhancing the survival of normal cells exposed to diverse acute and chronic stresses," said Susan Lindquist, a Howard Hughes investigator at the Whitehead Institute for Biomedical Research. "We expected it would have some effect on cancer, but we were surprised at the degree."

The heat-shock response is one of the most ancient and evolutionarily conserved protective mechanisms found in nature, the researchers said. While environmental insults provoke a variety of adaptive physiological responses to help organisms cope with specific stressors, the dramatic induction of heat-shock proteins (HSPs) is an essential unifying component of most of them.

The HSPs, which are under the control of a small family of heat-shock factors (HSFs), guard against the abnormal activity of other proteins in the face of stressors such as heat and oxygen starvation. Although less well understood, Lindquist said, HSFs also influence an array of other genes involved in cell metabolism and other basic cell functions. Scientists had also long noted that HSP levels increase in many cancer cells.

"The odd thing is, apparently no one thought it was that interesting," Lindquist said. Therefore, whether the stress management proteins played a causal, supportive, or inhibitory role in cancer remained an unanswered question. "On the one hand, given its prominent role in helping cells cope with stressful insults, HSF1 might promote [cancer's formation] by facilitating cellular adaptation to the malignant lifestyle," she explained. "On the other hand, given its general role in enhancing longevity, HSF1 might assist organisms in combating malignancy."

To find out, the researchers first looked to a common mouse model of skin cancer, in which the animals' are exposed to cancer-causing chemicals. Mice unable to switch on the heat-shock response were "far more resistant" to tumor formation than normal mice were under those conditions, they found. It took the mutant mice five weeks longer to develop tumors. They were less likely to develop cancer and, when they did, had fewer and smaller tumors. The HSF1-deficient mice also lived longer.

The researchers next examined mice predisposed to develop cancer due to a deficiency of the tumor suppressor p53, the most frequently mutated gene in human cancers. Again, they found, the HSF1-deficient animals lived tumor-free for dramatically longer. Indeed, even cancer-prone animals lacking just one working copy of HSF1 lived longer than normal animals did. Through studies in cultured mouse cells, they found further evidence that HSF1 supports the transformation to cancer by orchestrating a variety of basic cell functions, including proliferation, survival, protein synthesis, and glucose metabolism.

They then examined the role of HSF1 in normal and cancerous human cells, including those derived from the breast, prostate, and cervix. In every case, they found that the cancerous cells, but not the normal cells, were strongly affected by HSF1's inhibition. Those findings led them to conclude that "HSF1 function helps to maintain the growth and survival of human cancer cells with diverse underlying malignant defects."

The results may have therapeutic implications, the researcher said, as an expanding array of small, drug-like compounds with potent effects on HSF1 are now becoming available. Indeed, drugs that ramp up the heat-shock response are being explored for treating ischemic injury and neurodegenerative diseases, including Huntington's and Parkinson's diseases.

The new findings raise concern that such therapies might increase the risk of cancer, Lindquist said. On the other hand, treatments designed to block HSF1 might "provide a multifaceted and broadly effective cancer chemopreventative as well as chemotherapeutic strategy."

The results also point to the delicate balance between aging, longevity, and cancer risk, she added.

"Strikingly, our data now make clear that HSF1 plays opposite roles in the complex diseases that plague aging populations," she said. "It powerfully potentiates the development of cancers. But it has also been implicated in protection against ischemia/re-perfusion injury, neurodegenerative disorders and in other broad-ranging physiological processes affecting lifespan. We are poised on the balance between aging and degeneration [on one side] and the active, youthful cell growth, [which can lead to cancer], on the other. If we pay more attention and learn how to manipulate these systems properly, we could have a huge impact on human disease."


'/>"/>

Contact: Nancy Wampler
nwampler@cell.com
617-386-2121
Cell Press
Source:Eurekalert

Related medicine news :

1. Respecting Dwarfs- A Lesson To Be Learnt From Ancient Egyptians
2. Scientists found ancient Human Germ Killer
3. A Plant Used By Ancient Britons Found To Have Properties To Fight Cancer
4. Mining of Ancient Herbal Text Leads to Potential New Anti-Bacterial Drug
5. Ancient Herbal Text Paves the Way to Novel Anti-bacterial Drug
6. Mining of Ancient Herbal Text Leads to Potential New Anti-Bacterial Drug
7. Ancient Genes Used to Produce Salt-Tolerant Wheat
8. Ancient Worm Disease Could Be Eradicated Within Two Years, UN Agency Reports
9. Ancient Indian Herb May Prove Cure For Recurrent UTI
10. Ancient Healing Technique Gains New Popularity in Iraq
11. Ancient Ancestors Might Have Had a Clue to HIV
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... Beach, CA (PRWEB) , ... June 25, 2016 , ... ... UCLA with Magna Cum Laude and his M.D from the David Geffen School of ... Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at the ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association (PHA) ... will receive two significant new grants to support its work to advance research ... anniversary by recognizing patients, medical professionals and scientists for their work in fighting ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain ... for a minimum wage raise to $12 an hour by 2020 and then adjusting it ... the lost value of the minimum wage, assure the wage floor does not erode again, ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
(Date:6/24/2016)... , June 24, 2016 The Academy ... of recommendations that would allow biopharmaceutical companies ... with entities that make formulary and coverage decisions, a ... "value" of new medicines. The recommendations address ... not appear on the drug label, a prohibition that ...
(Date:6/24/2016)... , June 24, 2016 According ... by Type (Standard Pen Needles, Safety Pen Needles), Needle ... GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) - ... This report studies the market for the forecast period ... reach USD 2.81 Billion by 2021 from USD 1.65 ...
Breaking Medicine Technology: